Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019003053) ASSOCIATION COMPRISING OXYGEN AND HYALURONIC ACID FOR TOPICAL-VAGINAL USE.
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/003053 International Application No.: PCT/IB2018/054527
Publication Date: 03.01.2019 International Filing Date: 20.06.2018
IPC:
A61K 31/728 (2006.01) ,A61K 33/00 (2006.01) ,A61P 15/02 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
726
Glycosaminoglycans, i.e. mucopolysaccharides
728
Hyaluronic acid
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33
Medicinal preparations containing inorganic active ingredients
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15
Drugs for genital or sexual disorders; Contraceptives
02
for disorders of the vagina
Applicants:
MDM INDUSTRIAL S.R.L. [IT/IT]; Via dei Pioppi 6 Frazione Padulle 40010 Sala Bolognese BO, IT
Inventors:
CONDEMI, Leone; IT
Agent:
ASENSIO, Raffaella; IT
PERANI, Aurelio; IT
BONVICINI, Davide; IT
CICERI, Fabio; IT
GIRLANDO, Mario; IT
Priority Data:
10201700007095126.06.2017IT
Title (EN) ASSOCIATION COMPRISING OXYGEN AND HYALURONIC ACID FOR TOPICAL-VAGINAL USE.
(FR) ASSOCIATION COMPORTANT DE L'OXYGÈNE ET DE L'ACIDE HYALURONIQUE POUR UNE UTILISATION DANS LE TRAITEMENT TOPIQUE DE TROUBLES VAGINAUX
Abstract:
(EN) The present invention relates to an association comprising molecular oxygen and hyaluronic acid for use in the topical treatment of vaginal disorders and, more preferably, for the treatment of vaginal dryness and vulvovaginal atrophy.
(FR) La présente invention concerne une association comportant de l'oxygène moléculaire et de l'acide hyaluronique pour une utilisation dans le traitement topique de troubles vaginaux et, de préférence, pour le traitement de la sécheresse vaginale et de l'atrophie vulvo-vaginale.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: Italian (IT)